Until recently, the role of the proteolytic system involving serine proteases in follicle rupture during ovulation in mammalian species has been a subject of controversy. We undertook the present study to examine whether proteases play a role in follicle rupture using the teleost medaka (Oryzias latipes) model. Various serine protease inhibitors, including a specific plasmin inhibitor, drastically reduced the rate of ovulation, as assessed by an in vitro ovulation assay, which was established for the fish. Biochemical, molecular biological, and immunological analyses demonstrated that plasminogen/plasmin was present in large follicles destined to ovulate. The active protease, plasmin, was detected in follicles approximately 3-7 h before the expected time of ovulation. Specific antibodies against the medaka plasmin light chain suppressed the ovulation rate of the follicles when antibodies were added to the medium during the period in which active plasmin was generated. This finding was an indication that a plasmin-like protease similar if not identical to plasmin plays a role in follicle rupture during ovulation in the medaka. Our data also indicate that this serine protease participates in the rupture for only a few hours prior to the activation of matrix metalloproteinase (Mmp)-mediated hydrolysis at ovulation. Based on our previous and current data, we propose a follicle rupture model involving two different proteolytic enzyme systems, serine protease and Mmp, in medaka ovulation. The current study is the first to provide evidence of the indispensable role of plasmin or a plasmin-like protease in the ovulation of a nonmammalian vertebrate species.
INTRODUCTION
Ovulation is the unique process by which fully grown ovarian follicles respond to the surge of luteinizing hormone (LH) [1] . The LH surge triggers structural and biochemical changes that lead to rupture of the ovarian surface adjacent to the apex of the follicle, resulting in the expulsion of oocytes. A major challenge in ovulation research is to identify proteases involved in the rupture of ovulating follicles. A variety of proteolytic enzyme candidates have been proposed in mammals. They include matrix metalloproteinases (MMPs) [2, 3] , plasminogen activators (PAs)/plasmin [4, 5] , cathepsin L [6] , and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) [6, 7] . Based on both expression and functional studies, the above proteases might play a role in the regulation of ovulation by modulating the extracellular microenvironment. However, a definite causal connection has yet to be established. To date, no defects in female reproductive activity have been observed by the examination of mice deficient in these proteases, with the exception of a deficiency in ADAMTS1 [7] . ADAMTS1 plays a role in ovulation by cleaving versican in the matrix of the expanded cumulusoocyte complex [8] . In short, the question of which proteases are critical for follicle rupture during ovulation in mammals has not yet been answered [1, 9] .
In all vertebrates, ovary activities, such as the growth and proliferation of oogonia, development to the oocyte stage, and eventual release from the ovaries, are controlled by similar endocrine regulation mechanisms [10, 11] . Therefore, the use of appropriate animal models other than mammalian species may help to define the fundamental mechanisms that are common to vertebrate ovaries. The medaka, Oryzias latipes, is a small, convenient, prolific freshwater teleost, which serves as a vertebrate animal model in various fields of biology research [12] [13] [14] [15] [16] . In particular, this species is suitable for studies on the hypothalamic-pituitary-gonadal reproductive axis, ovarian steroidogenesis, oocyte maturation, and ovulation. In fact, using an in vitro ovulation system, we have demonstrated that follicle rupture during ovulation in the medaka involves the cooperation of at least three Mmps: membrane type-1 MMP (MT1-MMP, official symbol Mmp14), MT2-MMP (official symbol Mmp15), and gelatinase A together with the tissue inhibitor of metalloproteinase-2b protein [17] .
For mammalian ovaries, several lines of indirect evidence have implicated the PA/plasmin system in the degradation of the follicle wall during ovulation. First, inactive precursor plasminogen, from which plasmin is proteolytically produced by tissue-type PA (tPA) or urokinase-type PA (uPA), is present in the follicular fluid [4] . Second, PA activity is induced by gonadotropin treatment at the area of rupture in the follicle wall during ovulation [18, 19] . Last, the administration of either plasmin inhibitors or antibodies significantly suppresses ovulation [19, 20] . Although the findings of such studies conducted up to the early 1990s collectively support the obligatory role of the proteolytic system at the early stage of follicle rupture [21] , subsequent investigations using mice carrying a null mutation for either the plasminogen [22] , tPA [23, 24] , or uPA [23, 24] gene did not support this hypothesis. Currently, it is generally thought that the PA/plasmin system would be immaterial for ovulation in mammals [1, 22] .
In a preliminary experiment using an in vitro ovulation system established for the medaka, we found that in addition to Mmp inhibitors, the use of serine protease inhibitors resulted in a drastic reduction in the rate of ovulation under certain conditions. This finding suggested the involvement of a serine protease(s) in fish ovulation, which sparked our interest in conducting the present study. In this study, we report that in the medaka active plasmin, which is thought to be nonessential for follicle rupture during ovulation in mammals, is produced for a term of only a few hours in the large preovulatory follicle. We also show that a specific plasmin inhibitor and antiplasmin light-chain antibodies inhibited in vitro follicle ovulation when they were added to the medium during the period in which active plasmin was generated, thereby demonstrating that plasmin plays a critical role in follicle rupture upon ovulation. Our present data also indicate that plasmin participates in the rupture prior to activation of Mmp-mediated hydrolysis occurring at the time of ovulation.
MATERIALS AND METHODS

Medaka and Tissue Preparations
Mature medaka (Oryzias latipes) were purchased from a local dealer and stored at 288C under artificial reproductive conditions (constant long photoperiod, 14L:10D). After becoming acclimated to the conditions, female fish ovulated in vivo each day at the start of the light period. In this study, the start of the light period was set to 0 h, which corresponded to the expected time of ovulation. The ovaries and other tissues were collected at various time points. The experimental procedures used in this study were approved by the Committee of the Center for Experimental Plants and Animals, Hokkaido University.
In Vitro Ovulation
In vitro ovulation was performed as previously described [17] with a minor modification. Briefly, large follicles isolated at either 4 or 12 h before the expected time of ovulation were placed in a dish containing 50 lM gentamicin (Wako, Osaka, Japan) in 90% medium 199 solution (pH 7.4). At 3 or 11 h before ovulation, inhibitors were added, and the number of oocytes that had successfully ovulated was counted at 4.5 h after the expected ovulation time. Large follicles were incubated either with or without protease inhibitors or purified specific antibodies to assess their effects on in vitro ovulation. The concentrations of inhibitors and antibodies were as follows: GM6001 (Chemicon/Millipore, Bedford, MA), 10 lM; antipain (Peptide Institute, Osaka, Japan), 0.1 mM; soybean trypsin inhibitor (SBTI) (Sigma-Aldrich, St. Louis, MO), 0.1 mg/ml; aprotinin (Peptide Institute), 0.01 mg/ml; leupeptin (Peptide Institute), 0.02-0.2 mM; plasmin inhibitor (Calbiochem/Merck KGaA, Darmstadt, Germany), 0.2-20 lM; E-64 (Peptide Institute), 0.2 mM; pepstatin (Peptide Institute), 10 lM; purified antibody fractions (this study), 200 lg/ml; and control IgG (this study), 200 lg/ml. IgG fractions prepared from preimmune rabbit antiserum by means of a protein G-Sepharose column (GE Healthcare Biosciences, Piscataway, NJ) were used as controls. The concentrations of inhibitors used were those generally reported in the literature dealing with proteolytic enzymes. The concentrations of the antibody used for ovulation inhibition experiments were determined based on the results of preliminary tests.
Isolation of Oocyte Egg Membranes and Follicle Layers from Large Follicles
Large follicles were isolated from fish ovaries at various points within 12 h of the expected ovulation time. The follicle layer surrounding the oocyte was further mechanically removed from the follicle with forceps. The oocyte-free follicles are referred to as the ''follicle layer.'' The remaining naked oocytes were collected, homogenized in PBS containing 5 mM EDTA and 0.2 mM E-64, and centrifuged at 1000 3 g for 10 min. The resulting precipitate was obtained and is known as the ''egg membrane.'' The fractions of follicle layer and egg membrane were assessed via Western blot analysis to determine the localization of plasminogen/plasmin in the preovulatory follicle.
Plasminogen/Plasmin Purification
Medaka bodies (15 fish) were homogenized in 25 ml of 50 mM Tris-HCl (pH 8.0) containing 0.5 mM NaCl, 5 mM EDTA, and 0.2 mM E-64 and centrifuged at 13 000 3 g for 10 min. The resulting supernatant was filtered using a 0.45-lm filter and subjected to column chromatography on a lysineSepharose column (GE Healthcare Biosciences). The column (3 ml lysineSepharose gel) was washed with the same buffer and then eluted with a buffer containing an additional 0.2 mM 6-aminocaproic acid (Sigma-Aldrich). Eluted fractions were dialyzed against the buffer and concentrated. Active site titration was performed as previously described [25] . A total of 98 medaka ovaries were collected for analysis of the N-terminal amino acid sequence of the plasmin light chain. The enzyme purification was conducted as described above but on a one-third scale using the same buffer and affinity gel.
Cloning
A computer search for the identification of the medaka plasminogen gene was performed using the Ensembl genome browser (release 58) (http://uswest. ensembl.org/index.html). To amplify the cDNA fragment of the gene, RT-PCR was performed using KOD FX polymerase (Toyobo, Osaka, Japan). The amplified product was 1-1695 sequence (ENSORLG00000020532). To obtain full-length cDNA sequences of the gene, 5
0 -rapid amplification of cDNA ends (RACE) and 3 0 -RACE were performed [26] . The plasminogen sequence determined in this study has been deposited into the NCBI database (AB178523).
Molecular Phylogenetic Analysis
The amino acid sequences for medaka plasminogen (AB178523); medaka trypsinogen (AB272106); medaka enteropeptidase-1 (AB272104); medaka enteropeptidase-2 (AB272105); medaka tPA (AB178522); medaka uPA (AB573883); medaka kallikrein-like protein (AB242321); medaka elastase, neutrophil expressed (ENSORLP00000005672); medaka chymotrypsin C-a (ENSORLP00000005768); medaka chymotrypsin C-b (ENSORLP 00000005703); and medaka chymotrypsin-like elastase family, member 1 (ENSORLP00000008751) were obtained from the GenBank/EMBL/DDBJ sequence database or the Ensembl genome database (http://ensembl.org/index. html). A phylogenetic tree was constructed based on the amino acid sequences of the serine protease domain using DNASIS Pro software (Hitachi, Tokyo, Japan). The statistical significance was evaluated by bootstrap analysis with 1000 iterative tree constructions.
Northern Blot Analysis
Northern blot analysis was performed as previously described [17] . The probes utilized are listed in Table 1 .
Preparation of Recombinant Proteins
Recombinant medaka plasminogen light chain and b-actin were produced using an Escherichia coli expression system ( Table 2 ). The coding regions of the light chain and b-actin were amplified by PCR with a KOD plus NEO-DNA polymerase (Toyobo) using ovary cDNA. PCR products were digested by EcoRI and HindIII, and the digested products were subsequently ligated into a pET30a vector (Novagen, Madison, WI) previously digested with the same restriction enzymes. The resulting vectors were confirmed by nucleotide sequencing and transformed into E. coli strain Rosetta (Novagen). Recombinant protein expression and purification on a Ni 2þ -Sepharose column were performed as previously described [25] .
Preparation of Active Recombinant Medaka Plasmin
For functional analysis of medaka plasmin, recombinant plasminogen containing an enteropeptidase-cleavage site was expressed using 293T cells, and the precursor protein was subsequently activated by medaka enteropeptidase [25] . Specifically, two PCR products were first amplified using cDNA fragments containing the entire coding sequence of medaka plasminogen. The primer sets used were 5 0 -CGGGAATTCATGGATTTCTGCTGG AAAGC-3 0 (sense-1), 5 0 -CTTATCGTCGTCATCGCGTCCAAAGCAGGG-3 0 (antisense-1), 5 0 -GATGACGACGATAAGATCGTTGGCGGCTGT-3 0 (sense-2), and 5 0 -CCGCTCGAGGCCGGCTTTCATGGTCGTCTCA-3 0 (antisense-2). The subsequent PCR was conducted using a mixture of these amplified DNAs with the sense-1 and antisense-2 primers described above. The resulting complete DNA sequences, which contain an EcoRI and an XhoI site in the 5 0 and 3 0 regions, respectively, were digested with EcoRI and XhoI and were ligated into the pCMV tag4 vector (Stratagene, La Jolla, CA). The resulting vector was transfected into 293T cells using Lipofectamine 2000 (GE Healthcare Biosciences) and cultured in Opti-MEM I Reduced-Serum medium (Invitrogen, Carlsbad, CA). The conditioned medium was collected at 48 h after transfection and concentrated 20 times. The recombinant plasminogen possessed five extra amino-acid residues of an enteropeptidase-cleavage site (Asp-Asp-Asp-Asp-Lys) between the NH 2 -terminal heavy chain and the COOH-terminal light chain. The concentrated sample was subsequently treated OGIWARA ET AL.
with medaka enteropeptidase to convert single-chain plasminogen into active two-chain plasmin [25] .
Preparation and Purification of Antibody
Specific antisera were raised by injecting rabbits with 200 lg of the protein emulsified with Freund complete adjuvant. Boosting was started 2 wk later by injecting each rabbit at 2-wk intervals with 100 lg of the antigen with Freund incomplete adjuvant. Boost injections were conducted four times. After 2 wk from the final injection, sera were collected and stored at À208C until use. Specific antibody was purified using membranes onto which pure antigens were blotted [17] prior to use in Western blotting and immunohistochemistry. For the ovulation inhibitory assay, specific antibody was purified using affinity chromatography on a column containing antigen coupled to CNBr-activated Sepharose 4B (GE Healthcare Biosciences).
Polyacrylamide Gel Electrophoresis
Tissue extracts and recombinant proteins were analyzed by PAGE using either 6%, 8%, or 13% gel in SDS in the presence (reducing condition) or absence (nonreducing condition) of b-mercaptoethanol. Next, gels were stained with 0.25% Coomassie brilliant blue R-250 (CBB). Molecular mass standards used were myosin (200 kDa), b-galactosidase (116 kDa), phosphorylase b (97 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa), and carbonic anhydrase (31 kDa). Samples were loaded at 0.05-60 lg per lane.
Western Blot Analysis
Tissues were homogenized in PBS containing 5 mM EDTA and protease inhibitor mixture (Wako) and centrifuged at 13 000 3 g for 10 min. The resulting supernatants were used directly for Western blot analysis. Egg membranes were boiled in PBS containing 1% SDS for 20 min and centrifuged at 13 000 3 g for 10 min; the resulting supernatant was subjected to Western blot analysis. Follicle layers homogenized in PBS containing 5 mM EDTA and protease inhibitor mixture (Wako) were centrifuged at 13 000 3 g for 10 min to obtain precipitated materials. The materials were suspended in 50 mM Tris-HCl (pH 8.0) containing 150 mM NaCl, 1% Triton X-100, and 0.1% SDS and incubated for 120 min at 48C. The materials were then centrifuged at 13 000 3 g for 10 min and the supernatants were subjected to Western blot analysis. The protein concentration was determined using a Pierce BCA Protein Assay Reagent kit (Thermo, Rockford, IL). Extracts were subjected to SDS-PAGE, and separated polypeptides were transferred to polyvinylidene difluoride (PVDF) membranes (Millipore). Purified specific antibody was used as primary antibodies. Signals were detected using an Immobilon Western substrate (Millipore).
N-Terminal Amino Acid Sequence Analysis
The plasminogen/plasmin sample purified from the medaka ovaries was subjected to SDS-PAGE under reducing conditions. The separated polypeptides were transferred to PVDF membranes (Millipore) and stained with CBB. The protein band corresponding to plasmin light chain (30 kDa) was excised from the membrane and analyzed by automated Edman degradation [27] . A Procise 492 Sequencer (Perkin Elmer, San Jose, CA) was used for amino-acid sequence analysis.
Plasmin Activity Assay
Enzyme activity assays were performed as described previously [28] . Briefly, enzyme samples were incubated in 0.5 ml of 0.1 M glycine-NaOH (pH 9.5) with 0.1 mM synthetic peptide substrates containing 4-methylcoumaryl-7-amide (MCA) (Peptide Institute) for 30 min at 378C. The reaction was stopped by adding 2.5 ml of 0.1 M chloroacetic acid and 30 mM NaOAc (pH 4.3). The release of 7-amino-4-methylcoumarin (AMC) was measured by spectrofluorometer using an exciting wavelength of 370 nm and an emission wavelength of 460 nm. Enzyme activity was expressed as the amount of AMC released under the conditions. In some experiments, enzyme activity was determined in the presence of protease inhibitors. The concentrations of inhibitors in the assay mixture of 0.5 ml were as follows: E-64, 0.2 mM; EDTA, 5 mM; pepstatin, 10 lM; chymostatin, 0.1 mM; antipain, 0.1 mM; aprotinin, 0.01 mg/ml; leupeptin, 0.2 mM; SBTI, 0.1 mg/ml; benzamidine, 0.2 mM; and plasmin inhibitor, 20 lM. After incubating at room temperature for 5 min, activity levels were determined using Boc-Val-Leu-Lys-MCA.
Gelatin Zymography
Gelatin zymography was performed as previously described [17] , except that 0.1 M glycine-NaOH (pH 9.5) was used as the incubation buffer.
Protein Substrate Digestion by Plasmin
Ten micrograms of either bovine collagen type I (Sigma), bovine collagen type IV (Sigma), bovine plasma fibronectin (Sigma), mouse laminin (Sigma), or human fibrinogen (Calbiochem) was incubated in 20 ll of 0.1 M glycineNaOH (pH 9.5) with or without native plasmin (50 ng) for 1 h at 378C. After incubation, samples were mixed with 5 ll SDS-PAGE sample buffer and boiled for 10 min. Next, the samples were subjected to SDS-PAGE under reducing conditions. After electrophoresis, gels were stained with CBB.
Immunohistochemistry
Ovaries at 9 h before ovulation were fixed in 0.2 M Na 2 HPO 4 and KH 2 PO 4 (pH 7.4) containing 4% paraformaldehyde (Wako) and dehydrated in a graded ethanol series. The specimen was incubated twice in methyl benzoate (Wako) for 30 min and incubated twice in benzene (Wako) for 10 min. The resulting specimen was embedded in paraffin. Paraffin was removed from cut sections (10 lm) by incubation in xylene (Wako) and rehydrated through a series of alcohol treatments. The sections were then incubated in 3% H 2 O 2 for 10 min and washed three times in PBS. After washing, the sections were incubated in Block Ace (Dainippon Sumitomo Seiyaku Inc., Osaka, Japan) for 60 min. Next, the sections were exposed to purified primary antibody diluted in PBS for 60 min and washed three times in PBS. After washing, they were incubated in DAKO EnVision rabbit (DAKO, Copenhagen, Denmark) for 60 min and washed three times in PBS. Signals were detected using an AEC kit (Vector Laboratories, Burlingame, CA) according to the manufacturer's instructions. The antibody previously treated with recombinant medaka plasminogen protein was used as a control.
Statistical Analysis
All experiments were repeated two to four times, and data are expressed as the mean 6 SEM. Statistical differences were determined by Student t-test, and a difference with a P value of ,0.05 was regarded as significant.
RESULTS
Inhibition of In Vitro Ovulation by Serine Protease Inhibitors
We have previously reported that extracellular matrix (ECM) degradation by the cooperative actions of three Mmps, namely, Mmp14, Mmp15, and gelatinase A, at the time of PLASMIN DURING MEDAKA OVULATION ovulation was a critical event closely associated with follicle rupture during ovulation in the medaka [17] . In the present study, the effects of protease inhibitors were reexamined using an in vitro ovulation system (Fig. 1, A and B) to gain insight into the role that other types of proteases play during the preovulatory period. In follicles isolated at 12 h before the time of ovulation, the Mmp inhibitor GM6001 was found to inhibit in vitro ovulation irrespective of whether the compound was added 3 or 11 h before ovulation (Fig. 1C) , a result consistent with that of our previous report [17] . However, serine protease inhibitors, such as antipain, SBTI, aprotinin, and leupeptin, drastically reduced the rate of ovulation when they were added at 11 h but not at 3 h before the expected time of ovulation. Because the involvement of plasmin in follicle rupture during ovulation in mammals has already been described [19, 20] , the effect of a plasmin inhibitor was also examined. The inhibitor prevented ovulation by approximately 90%. For the leupeptin and plasmin inhibitors, the concentration-dependent effects on the ovulation were examined. The concentrations required to inhibit the ovulation by 50% were 80 lM and 10 lM for the leupeptin and plasmin inhibitors, respectively (Fig. 2) . The results justify the specificity of the serine protease inhibitors for ovulation inhibition. These results suggest that proteolysis catalyzed by a serine protease(s) is required for follicle rupture during ovulation in the medaka and that an additional proteolytic event precedes MMP-mediated ECM degradation in the ovulating follicle.
Enzymatic Characterization of Medaka Plasmin
In preliminary experiments, we found that extracts of fish ovary and large follicles contained enzyme activity detectable with the synthetic substrate Boc-Val-Leu-Lys-MCA, which is a well-known substrate for plasmin. Therefore, we hypothesized that either plasmin or a plasmin-like enzyme may play a critical role in medaka ovulation. To determine the chemical characteristics of the Boc-Val-Leu-Lys-MCA-hydrolyzing protease, the enzyme was purified from fish ovaries using a Lys-Sepharose column, which is usually employed as a powerful means of purification for mammalian plasmin [29] . Single-step affinity chromatography using the column yielded the enzyme sample in an apparently pure state. The purified enzyme had a specific activity of 1.8 lmol mg À1 min À1 , which represented an approximately 74-fold purification compared with the crude extract (specific activity: 24.3 nmol mg À1 min À1 ). SDS-PAGE analysis of the purified enzyme indicated three polypeptides (90, 66, and 30 kDa) and a single polypeptide (72 kDa) under reducing and nonreducing conditions, respectively (Fig. 3) . The 72-kDa polypeptide displayed gelatin-degrading activity.
The substrate specificity of the purified enzyme was examined using various synthetic peptide substrates, and the results are shown in Figure 4A , in which the specificity of recombinant medaka plasmin was also included for comparison. The purified enzyme hydrolyzed the plasmin substrate Boc-Val-Leu-Lys-MCA the most rapidly. Boc-Gln-Ala-Arg-MCA was the second most effective substrate. The enzyme also cleaved Boc-Gln-Lys-Lys-MCA and Pro-Phe-Arg-MCA to considerable extents. Relative activities toward the substrates tested were essentially the same for the purified enzyme and recombinant medaka plasmin. The inhibitor profile of the purified enzyme was similar to that of recombinant medaka plasmin (Fig. 4B) . Serine protease inhibitors, such as antipain, aprotinin, leupeptin, SBTI, and benzamidine, strongly inhibited both enzymes. The plasmin inhibitor, which suppressed the in vitro ovulation of large follicles, was a potent inhibitor of the purified enzyme as well as the recombinant plasmin. These results strongly suggest that the medaka ovary serine protease is probably plasmin.
We tested the effects of medaka plasmin on several ECM proteins and fibrinogen, a well-known plasmin substrate [30] . Plasmin degraded collagen type I, fibronectin, laminin, and fibrinogen, but failed to degrade collagen type IV (Fig. 5) .
To substantiate this hypothesis further, studies of cloning and expression and immunological analyses of medaka plasminogen were conducted. A cDNA coding for medaka plasminogen (797 residues) was obtained (NCBI accession no. AB178523). Specific antibodies were produced against recombinant medaka plasminogen and were tested against the purified Boc-Val-Leu-Lys-MCA-hydrolyzing enzyme by Western blot analysis. The 90-and 30-kDa polypeptides (reducing conditions) and the 72-kDa polypeptide (nonreducing conditions) were recognized by plasmin light-chainspecific antibodies in these assays (Fig. 3) . As the antibodies employed were raised against the recombinant catalytic domain of medaka plasminogen, they did not detect the N-terminal 66-kDa heavy chain of plasminogen.
The N-terminal amino acid sequence of eight residues was determined for the 30-kDa polypeptide separated in SDS-PAGE under reducing conditions (Fig. 3) . The analysis gave a sequence of NH 2 -Ile-Val-Gly-Gly-X-Gln-Ser-Arg-in which the fifth residue was not identified. This sequence was identical to the amino acid sequence ranging from Ile 568 to Arg 575 of that deduced from the nucleotide sequence of medaka plasminogen (NCBI accession no. AB178523).
FIG. 3.
Purification of medaka plasminogen/plasmin. Plasminogen/ plasmin purified from the fish was analyzed by SDS-PAGE followed by CBB staining (CBB), Western blot analysis (WB), or gelatin zymography (GZ). Positions of standard marker proteins and plasminogen (Plg), plasmin heavy chain (HC), plasmin light chain (LC), and plasmin (Plm) are indicated. Protein quantities loaded were 2 lg (for CBB) and 50 ng (for WB and GZ).
FIG. 4.
Comparison of enzymatic activity between native and recombinant plasmin. A) Synthetic peptide substrates containing MCA were tested for the purified enzyme (white bars) and recombinant plasmin (black bars). Aliquots of enzyme samples (50 ng for the purified enzyme and 100 ng for recombinant plasmin) were used in a 0.5-ml assay system. Enzyme activity relative to that of Boc-Val-Leu-Lys-MCA is shown. Values represent the mean 6 SEM of three determinations. Boc, t-butyloxycarbonyl; Z, benzyloxycarbonyl; Pyr, pyroglutamyl; Suc, succinyl. B) Effects of protease inhibitors were examined for the purified enzyme (white bars) and recombinant plasmin (black bars) using Boc-Val-Leu-Lys-MCA. Aliquots of enzyme samples (50 ng for the purified enzyme and 100 ng for recombinant plasmin) were used in a 0.5-ml assay system containing one of the protease inhibitors. Values represent the mean 6 SEM of three determinations.
PLASMIN DURING MEDAKA OVULATION
To gain insight into the occurrence of other plasmin-like serine proteases in the medaka genome, a phylogenetic tree was constructed based on the amino acid sequences of the serine protease catalytic domains (Fig. 6) . The results indicated that, although medaka plasmin is similar to medaka trypsin, it clearly falls into a different subgroup based on their phylogenetic analysis. The results also suggest the absence of plasmin paralogs in the medaka genome.
Based on these results, we concluded that the enzyme purified from the extracts of medaka ovaries is plasmin; the 90-, 66-, and 30-kDa polypeptides separated by SDS-PAGE under reducing conditions were presumed to be the single-chain inactive precursor plasminogen and the heavy chain and light chain of medaka plasmin, respectively.
Expression of Plasminogen mRNA and Protein in Medaka Tissues
The expression of plasminogen mRNA was examined by Northern blot analysis. A 2.9-kb plasminogen transcript was detected in the liver, kidney, heart, spleen, intestine, and brain of the medaka (Fig. 7A) . No signal for plasminogen transcript was observed in the fish ovary. However, plasminogen mRNA was expressed exclusively in the livers of mice (Fig. 7B) .
Plasminogen protein (90 kDa) was detected by Western blot analysis in all medaka tissue extracts examined, except in the intestine (Fig. 8) . However, the 30-kDa polypeptide (light chain) was visible only in the ovary, intestine, kidney, and spleen.
Localization of Plasminogen/Plasmin in the Ovary
We further examined the expression of plasminogen/ plasmin in the fish ovary by immunohistochemical analysis. Plasminogen/plasmin was localized in the egg membrane, but not the plasma membrane, of the oocytes in all growing follicles (Fig. 9) . Staining of the protein was also visible, albeit weakly, in association with the follicle layer of virtually all follicles. No staining was observed when the antibody previously treated with recombinant medaka plasminogen OGIWARA ET AL.
was employed, confirming the specificity of the antibody used in the present study.
Occurrence of Active Plasmin in the Preovulatory Follicle
Given the role of plasmin in ovulation, changes in the expression of the protein in preovulatory follicles of the mature fish in the latter half of the 24-h spawning cycle were examined. Using extracts from the whole follicle, only plasminogen was invariably detected throughout the period (Fig. 10) . When the egg membranes and follicle layers of large follicles were separated, the plasmin light chain was clearly detected in the follicle layer but not in the egg membrane (Fig.  10, middle and right panels) . The signal intensity corresponding to the light chain was strongest at 5 h before the expected time of ovulation, indicating that active plasmin is present in high abundance in association with the follicle layers of large preovulatory follicles around this time.
Suppression of In Vitro Ovulation by Specific Plasminogen/ Plasmin Antibodies
We examined the effect of specific antiplasmin light-chain antibodies on in vitro follicle ovulation. The antibodies PLASMIN DURING MEDAKA OVULATION significantly suppressed the rate of ovulation when added to the medium from the start of follicle culture (63 6 10%, P , 0.05; Fig. 11 ). However, the addition of the antibody to the medium 3 h before the expected time of ovulation did not affect the ovulation rate.
DISCUSSION
We initiated this study by examining whether serine proteases were involved in follicle rupture during ovulation using an in vitro ovulation system established for the medaka. Knowing that typical serine protease inhibitors had a strong inhibitory effect on fish ovulation, we attempted to identify the protease involved in the rupture. Several results obtained from biochemical and enzymological analyses of the protease demonstrated that the identified protease is plasmin. To the best of our knowledge, the present study reports a novel purification and characterization of plasmin from nonmammalian vertebrates. Our data reveal that medaka plasmin exhibits many features common to plasmins of mammalian species, including molecular size, heavy-and light-chain polypeptide arrangement, substrate specificity, and behavior toward inhibitors of the medaka protease. This fact undoubtedly highlights the biological importance of plasmin among vertebrates. An interesting finding on medaka plasmin was its wide tissue distribution. Transcripts of plasminogen were detected in several tissues of the medaka with the highest expression observed in the liver. Such a relatively wide expression pattern is unique to this nonmammalian vertebrate, as the expression of the mammalian plasminogen gene is highly restricted to the liver [31] .
The dissolution of the connective tissue matrix and collagen fibers in the follicle layers of ovulating follicles is essential for ovulation in mammals [1] . It is generally accepted that ECM proteins present in the follicle layers of ovulating follicles are collagen type I, which is associated with the theca cell layer, whereas collagen type IV and laminin are two major components of the follicle basement membrane. Our recent studies have indicated that collagen type I [32] and collagen type IV [33] are localized in the follicle layer of the follicle in the medaka. In addition, gelatinase A was activated by Mmp14 at the plasma membrane of the oocyte to hydrolyze collagen type IV, whereas Mmp15 degraded collagen type I [17] . However, none of these Mmps participate in the degradation of laminin. The present study shows that plasmin is capable of hydrolyzing this basement membrane protein in vitro. These considerations tempt us to speculate that plasmin might play a role in the degradation of laminin in vivo upon ovulation in the medaka. It is clear that in fish ovulation, the activation of plasmin precedes the activation of Mmp-mediated hydrolysis of ECM in the apex of follicles that are about to ovulate. Plasmin might bring about the perturbation of the basement membrane in the follicle layer of the ovulating follicle by partial hydrolysis of laminin. Such removal of laminin from the basement membrane could facilitate the proteolytic degradation of collagen type IV by the latter Mmp system, (especially by gelatinase A) [17] .
Fibronectin was found to be degraded in vitro by medaka plasmin, suggesting that this ECM protein could also be a substrate of the protease in vivo. Previous studies have demonstrated the presence of fibronectin in the follicle layers of ovarian follicles in mammals [34] [35] [36] [37] [38] , as well as in teleost fish [39] . Fibronectin is presumed to stabilize and maintain the ECM environment and normal cell adhesion by interacting with collagen type IV and the cell surface receptor protein integrin [37, 38] . In light of the involvement of fibronectin, hydrolysis of the protein by plasmin would be an event that accelerates the degradation process occurring at the follicle layers of follicles that are destined to ovulate.
Active plasmin was detected in the large ovulating follicle between 3 and 7 h prior to the expected time of ovulation. This observation indicates that the activation of plasminogen must be spatially and temporally regulated in the follicle in a strict manner. As revealed by immunohistochemical analysis, plasminogen/plasmin was predominantly localized to the oocyte egg membrane of the follicle. This suggests that plasmin may be generated at the egg membrane of the oocyte. As the medaka, similar to mammalian species, contains both the plau (also known as upa) and plat (also known as tpa) genes (from the Medaka Genome Sequence Database http:// www.ensembl.org/Oryzias_latipes/Info/Index), either or both of the PAs are presumed to be responsible for plasminogen activation. In addition, PA inhibitor genes (PA inhibitor 1 and PA inhibitor 2) were also found in the same medaka genome database. The important role that these inhibitors play has been well documented as regulating PA actions in a variety of biological processes. Therefore, investigations of PAs and PA inhibitors are necessary to understand fully the mechanism by which the active plasmin is detected only for several hours in the 24-h spawning cycle. We should note the origin of plasminogen/plasmin presence in the ovary, as the plasminogen gene was not transcribed in the reproductive organ in the fish. Similar to mammalian species, plasminogen may be derived from the liver, which produced plasminogen transcripts most abundantly in the fish via the circulatory system. The precursor protease may be extracellularly associated with the follicle cells and the egg membrane of the oocytes in the ovarian follicles. We cannot exclude, however, the possibility that other plasminogenexpressing organs, such as the spleen, kidney, heart, intestine, and brain, may contribute to the presence of plasminogen in the ovary.
Because recent evidence has argued against an essential role of the PA/plasmin system for follicle rupture during ovulation in mammals [1, [16] [17] [18] , the current finding that plasmin is involved in fish ovulation was rather surprising. Currently, it is not known whether this indispensable involvement of plasmin in follicle rupture is unique to the teleost fish. In this context, we should note a clear difference in the tissue structure of ovarian follicles between mammals and nonmammalian species. The mature follicle of mammals consists of a round oocyte and two types of somatic cells, granulosa cells and theca cells. Some of the granulosa cells surround the oocyte, forming the cumulus-oocyte complex, which protrudes toward the interior of the antrum filled with follicular fluid. Other granulosa cells reside just below the basement membrane in multiple cell layers to form the membrane granulosa. Theca cells are present in the outside of the basement membrane, and they also exist in multiple cell layers rich with ECM components [1, 40] . Meanwhile, a common tissue structure is generally observed for the mature follicle of nonmammalian species ranging from fish to birds [10, [41] [42] [43] : the mature follicle consists of a single layer of granulosa cells surrounding an oocyte, a single layer of theca cells, and the basement membrane located between the two layers. Such differences in follicular tissue structure between mammalian and nonmammalian species may have led to the evolution of the two distinct mechanisms for follicle rupture in the evolutionary process. We tentatively speculate that the indispensable role that plasmin plays in follicle rupture may be conserved for nonmammalian species. In favor of this speculation, a previous report by Tilly and Johnson [44] documented that PA activity was present in granulosa cells of the domestic hen and that the activity was modulated by a variety of hormonal factors.
It may be speculated that the enzyme involved in ovarian rupture is not plasmin but an enzyme having the characteristics of a serine protease. A sequence data search revealed that the amino acid sequences of medaka macrophage-stimulating 1 protein (Ensembl gene ID: ENSORLG00000003636) and medaka tPA (NCBI accession no. AB178522) are homologous to medaka plasminogen, with identities of 43% and 36%, respectively. When a homology search was conducted by limiting the criteria to the carboxyl-terminal serine protease domain of plasmin, medaka trypsinogen (40% identity) (NCBI accession no. AB272106) and the enteropeptidase catalytic domain (35% identity) (NCBI accession no. AB2721004) were found to be the proteins with the highest and second-highest homologies, respectively. Our current phylogenetic analysis suggests a closer relationship of medaka plasmin with medaka trypsin. The results also suggest that plasmin paralogs are not present in the medaka genome. Considering that the rate of in vitro medaka ovulation was suppressed by a plasmin inhibitor and antiplasmin light-chain antibodies, the activities of these putative serine proteases should be inhibited by both the inhibitor and the antibodies. However, at present, it is unknown whether their activities may be inhibited by specific plasmin inhibitors. Furthermore, reactivity of these proteases to the antibody is also unknown. Although additional studies are necessary to determine whether one of these serine proteases may play a role in follicle rupture during medaka ovulation, our current data strongly support the concept that plasmin is the protease responsible for the rupture.
Another interesting feature of medaka ovulation is that the plasmin-catalyzed proteolytic process and the Mmp-mediated process occur sequentially in follicle rupture. Because the inhibition of one of the two proteolytic processes by specific protease inhibitors or specific antibodies led to a nearly complete block in ovulation, the operation of both processes must be essential for successful ovulation. In this study, we propose a sequential two-step hydrolysis mechanism for follicle rupture in the medaka ovulation: plasmin is activated early on during the preovulatory stage and followed by activation of the Mmp system. In mammals, only an Mmp proteolytic system appears to play a significant role in the degradation of the collagenous connective tissue in the follicle wall upon ovulation [1] . Therefore, the finding that the actions of both plasmin and the Mmp system are required for ovulation is novel. It is conceivable that the role of plasmin in the preovulatory follicles is to activate the ovulation-related Mmps directly involved in the follicle rupture in fish ovulation. However, plasmin had no activating effect on the ovulationrelated Mmps (K. Ogiwara, unpublished results). This observation, together with the present results demonstrating that medaka plasmin is capable of hydrolyzing ECM proteins, supports the idea that plasmin plays a direct role in the process of follicle rupture at ovulation.
The present study provides evidence suggesting that plasmin plays an important role in medaka ovulation. This study presents the first demonstration of a clear link between the PA/plasmin system and follicle rupture in vertebrate ovulation. To confirm the role of the proteolytic system in vivo, it is necessary to establish gene-targeting technology in fish. Currently, knockout technology relying on homologous recombination does not exist for fish. Rather, the establishment of transgenic RNAi technology for the knockdown of fish genes might be more feasible. Further physiological studies await the availability of these novel methods. Nevertheless, the present findings extend our understanding of the nature of follicle rupture during ovulation in nonmammalian vertebrates.
